scholarly journals Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia

Cancer ◽  
1989 ◽  
Vol 63 (5) ◽  
pp. 813-817 ◽  
Author(s):  
Hagop M. Kantarjian ◽  
Michael J. Keating ◽  
Ronald S. Walters ◽  
Charles A. Koller ◽  
Kenneth B. McCredie ◽  
...  
Keyword(s):  
Continuous Infusion ◽  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Low Dose ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

A Phase II Study of Sequential Decitabine and Rapamycin in Acute Myelogenous Leukemia

2021 ◽  
pp. 106749
Author(s):  
Jane L. Liesveld ◽  
Andrea Baran ◽  
Mitra Azadniv ◽  
Haley Misch ◽  
Katherine Nedrow ◽  
...  
Keyword(s):  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia

2020 ◽  
Vol 20 (4) ◽  
pp. 226-233.e1
Author(s):  
Benjamin K. Tomlinson ◽  
Molly M. Gallogly ◽  
Donna M. Kane ◽  
Leland Metheny ◽  
Hillard M. Lazarus ◽  
...  
Keyword(s):  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Wild Type ◽  
Acute Myelogenous ◽  
Unfit Patients

A Phase II study of VNP40101M in elderly patients (pts) with de novo poor risk acute myelogenous leukemia (AML)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 7026-7026 ◽  
Author(s):  
G. J. Schiller ◽  
D. DeAngelo ◽  
N. Vey ◽  
S. Solomon ◽  
R. Stuart ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
De Novo ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Poor Risk ◽  
Acute Myelogenous

Phase II study of VNP40101M in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 6541-6541 ◽  
Author(s):  
F. J. Giles ◽  
S. O’Brien ◽  
N. Vey ◽  
E. Feldman ◽  
D. Rizzieri ◽  
...  
Keyword(s):  
High Risk ◽  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

scholarly journals Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

2013 ◽  
Vol 20 (2) ◽  
pp. 490-498 ◽  
Author(s):  
Nitin Jain ◽  
Emily Curran ◽  
Neil M. Iyengar ◽  
Ernesto Diaz-Flores ◽  
Rangesh Kunnavakkam ◽  
...  
Keyword(s):  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Study ◽  
Mek Inhibitor ◽  
Myelogenous Leukemia ◽  
University Of Chicago ◽  
Acute Myelogenous

scholarly journals Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

2016 ◽  
Vol 6 (10) ◽  
pp. 1106-1117 ◽  
Author(s):  
Marina Konopleva ◽  
Daniel A. Pollyea ◽  
Jalaja Potluri ◽  
Brenda Chyla ◽  
Leah Hogdal ◽  
...  
Keyword(s):  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous
Sign in / Sign up

Export Citation Format

Share Document